5Paisa Capital Ltd

5paisa Capital Ltd share price slipped 1.36% to Rs 345.7 after the company's net profit plunged by 38.98% to Rs 7.06 crore, while revenue from operations eased by 2.16% to Rs 86.42 crore in Q3FY26 over Q2FY26. The market capitalization of Stockbroking & Allied industry group stocks on BSE stood at Rs 3.37 lakh crore, gaining 8.84%. It has marginally improved by 2.46% over last one week and softened by 2.16% in last one month while the market capitalization of 5paisa Capital Ltd has inched up 2.17% and 5.44% in the same period respectively. Profit before tax (PBT) of 5paisa Capital Ltd stood at Rs 9.46 crore in Q3 FY26, crashing by 25.75% year-on-year, and plunging by 38.77% quarter-on-quarter. EBITDA came in at Rs 12 crore, tumbling by 17.29% YoY and tanking 30.01% sequentially. Total expenses grew marginally by 5.58% to Rs 77.0 crore in Q3FY26 over Q3FY25. During the quarter, employee benefits expense was at Rs 22.05 crore, softening 0.23% YoY. For the TTM ended FY26, revenue from operations fell 11.13% to Rs 319.56 crore, while net profit tanked by 35.23% to Rs 44.19 crore, compared to previous TTM. EBITDA soared by 9888% to Rs 67.84 crore, and PBT collapsed by 35% to Rs 59.29 crore compared to previous TTM. 5paisa Capital Ltd rallied 8.17% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 10.04% during the same period.

5paisa Capital Ltd share price declined by 1.36% to Rs 345.7 after the company's net profit tanked by 38.98% to Rs 7.06 crore, while revenue from operations softened by 2.16% to Rs 86.42 crore in Q3FY26 over Q2FY26. The market capitalization of Stockbroking & Allied industry group stocks on BSE stood at Rs 3.37 lakh crore, rising 8.84%. It has improved by 2.74% over last one week and eased lower by 2.16% in last one month while the market capitalization of 5paisa Capital Ltd has inched up 2.46% and 5.44% in the same period respectively. Profit before tax (PBT) of 5paisa Capital Ltd stood at Rs 9.46 crore in Q3 FY26, nosediving by 25.75% year-on-year, and tumbling by 38.77% quarter-on-quarter. EBITDA came in at Rs 12 crore, tanking 17.29% YoY and plunging by 30.01% sequentially. Total expenses saw a slight increase of 5.58% to Rs 77.0 crore in Q3FY26 over Q3FY25. During the quarter, employee benefits expense was at Rs 22.05 crore, registering a marginal contraction of 0.23% YoY. For the TTM ended FY26, revenue from operations dropped by 11.13% to Rs 319.56 crore, while net profit witnessed a sharp fall of 35.23% to Rs 44.19 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 9888% to Rs 67.84 crore, and PBT tumbled by 35% to Rs 59.29 crore compared to previous TTM. 5paisa Capital Ltd surged by 9.40% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 11.27% during the same period.

5paisa Capital Limited will hold a board meeting on Thursday, October 15, 2026, to consider and approve the consolidated and standalone unaudited financial results for the quarter and half year ended September 30, 2026, the company said in a filing with the BSE Limited and The National Stock Exchange of India Limited.

5paisa Capital Limited informed the BSE Limited and The National Stock Exchange of India that it has received a confirmation certificate from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, the Registrar to an Issue and Share Transfer Agent of the company, for the quarter ended September 30, 2026, pertaining to certificates under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

5paisa Capital Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2026, are approved by the board and filed with stock exchanges.

5paisa Capital Ltd announced that CRISIL Ratings Limited ("CRISIL") has reaffirmed ratings for its existing credit facilities and assigned a rating to additional Non-Convertible Debentures. Specifically, CRISIL reaffirmed a Crisil A+/Stable rating for Non-Convertible Debentures amounting to Rs 50 crore, a Crisil A+/Stable rating for a Long Term Bank Loan Facility of Rs 100 crore, and a Crisil A1+ rating for a Short Term Bank Loan Facility of Rs 300 crore; furthermore, the enhancement of the Commercial Paper facility was confirmed by CRISIL, increasing the amount from Rs 200 crore to Rs 400 crore, retaining the Crisil A1+ rating, and also assigned a Crisil A+/Stable rating to Non-Convertible Debentures of Rs 50 crore. The rating rationale is accessible on the CRISIL website at https://www.crisilratings.com.

5paisa Capital is acquiring 100% of Giskard Datatech Private Limited, a provider of data-driven technology solutions, for a combination of cash and a share swap. The deal, expected to close within six months pending regulatory approvals from SEBI, will see 5paisa pay up to Rs 121.57 crore (approximately $14.7 million USD) in cash for 58.68% of Giskard’s shares, alongside issuing 20,50,588 equity shares representing a 37.65% stake. The acquisition is intended to bolster 5paisa’s analytics and research capabilities, leveraging Giskard’s expertise and recent revenue growth, which reached Rs 15.75 crore in fiscal year 2024-25. The share swap will increase the holdings of Mr. Amber Pabreja and Ms. Devi Yeshodharan, significant shareholders in Giskard, to approximately 2.42% and 1.77% of 5paisa Capital, respectively.

5paisa Capital is acquiring 100% of Giskard Datatech Private Limited, a data-driven technology solutions provider and registered Research Analyst, in a deal involving both cash and a share swap. The acquisition, expected to close within six months pending regulatory approvals from the Securities and Exchange Board of India, will see 5paisa pay up to Rs 121.57 crore for 58.68% of Giskard’s shares and issue 2,050,588 equity shares, representing a 37.65% stake, to Giskard shareholders via a 1:31 swap ratio. The move is intended to expand 5paisa’s data analytics and research capabilities, with Giskard reporting revenue of Rs 15.75 crore in fiscal year 2024-25. The transaction will result in shareholdings of 2.42% and 1.77% for Mr. Amber Pabreja and Ms. Devi Yeshodharan, respectively, in 5paisa Capital.

5Paisa Capital will hold a meeting of the Board of Directors of the Company on 28 July 2026.

Net profit of 5paisa Capital rose 0.17% to Rs 11.57 crore in the quarter ended June 2026 as against Rs 11.55 crore during the previous quarter ended June 2025. Sales rose 13.70% to Rs 88.33 crore in the quarter ended June 2026 as against Rs 77.69 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales88.3377.69 14 OPM %29.5032.42 - PBDT17.6617.99 -2 PBT15.4515.50 0 NP11.5711.55 0 Powered by Capital Market - Live